Ask Our Doctors and Nurses!

FLUOROURACIL Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

FLUOROURACIL Safety Reports

Total FLUOROURACIL reports: 453.
FLUOROURACIL FDA safety alerts: 2005 .
Reported deaths: 76    Reported hospitalizations: 303.
Take FLUOROURACIL Side Effects Survey or Share Your FLUOROURACIL Story. Read More Here.

Showing 1-75 of 453 Next >

Health Professional from CANADA reported FLUOROURACIL problem on Mar 07, 2007. Female patient, 36 years of age, weighting 119.0 lb, was diagnosed with colorectal cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood potassium decreased, blood urea increased, blood uric acid increased, encephalopathy, muscular weakness. FLUOROURACIL dosage: 3675 MG OTH PU. During the same period patient was treated with FOLINIC ACID. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2007. Male patient, weighting 191.8 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: pneumonia. FLUOROURACIL dosage: 410 MG. During the same period patient was treated with CISPLATIN, EPIRUBICIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Mar 23, 2007. Female patient, weighting 101.6 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: bacterial infection. FLUOROURACIL dosage: 600MG/M2 ~QD. During the same period patient was treated with HYDREA, CETUXIMAB. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 30, 2007. Male patient, weighting 165.3 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: anaemia, faeces discoloured, nausea. FLUOROURACIL dosage: 3550 MG. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUOROURACIL problem on Mar 23, 2007. Male patient, 71 years of age, was diagnosed with colorectal cancer metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: pain. FLUOROURACIL dosage: 564 MILLIGRAM 1/2 WEEK, INTRAVENOUS. During the same period patient was treated with FOLINIC ACID, CETUXIMAB, BEVACIZUMAB, OLMESARTAN MEDOXOMIL, AMLODIPINE, VICODIN. Patient died on 02/18/2007.

FLUOROURACIL problem was reported by a Physician from UNITED STATES on Mar 14, 2007. Male patient, 79 years of age, was diagnosed with colorectal cancer metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood chloride increased, blood phosphorus decreased, blood potassium decreased, decreased appetite, dehydration, diarrhoea, disease recurrence, haematocrit decreased. FLUOROURACIL dosage: 50.2857 MG (704 MG, 1 IN 2 WK), INTRAVENOUS. During the same period patient was treated with CETUXIMAB, BEVACIZUMAB, LEUCOVORIN CALCIUM, SIMVASTATIN, CALTRATE, MAXIPIME, TOPROL, PROTONIX. Patient was hospitalized. Patient recovered.

Physician from POLAND reported FLUOROURACIL problem on Mar 19, 2007. Female patient, 47 years of age, was diagnosed with breast cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: paratracheal lymphadenopathy, pulmonary sarcoidosis. FLUOROURACIL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ANTIBIOTIC. Patient recovered.

FLUOROURACIL problem was reported by a Physician from JAPAN on Mar 22, 2007. Male patient, weighting 116.8 lb, was diagnosed with rectal cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. FLUOROURACIL dosage: unknown. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, DEXAMETHASONE PHOSPHATE. Patient recovered.

Health Professional from JAPAN reported FLUOROURACIL problem on Mar 23, 2007. Male patient, weighting 143.3 lb, was diagnosed with rectal cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: gastric ulcer. FLUOROURACIL dosage: 2500 MG/BODY=1488.1 MG/M2 AS CONTINUOUS INFUSION, D1-2. During the same period patient was treated with OXALIPLATIN, ISOVORIN. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from GREECE on Mar 23, 2007. Male patient, 52 years of age, was diagnosed with colon cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome. FLUOROURACIL dosage: DOSE: 400 MG/M2 BOLUS ON DAYS 1, 2 FOLLOWED BY 600 MG/M2 CONTINUOUS INFUSION FOR 22 HOURS. During the same period patient was treated with LEUCOVORIN CALCIUM. Patient recovered.

Physician from UNITED STATES reported FLUOROURACIL problem on Mar 23, 2007. Female patient, 47 years of age, weighting 207.0 lb, was diagnosed with depression, breast cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: apicectomy, asthma, bone disorder, bone graft, bone pain, bronchitis, cervix carcinoma, dental operation. FLUOROURACIL dosage: unknown. During the same period patient was treated with KLONOPIN, STEROIDS NOS, ABRAXANE, CLARITIN, CIPRO, NEURONTIN. Patient recovered.

FLUOROURACIL problem was reported by a Health Professional from FRANCE on Mar 27, 2007. Male patient, 54 years of age, was diagnosed with rectal cancer, asthma and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: cardiogenic shock. FLUOROURACIL dosage: unknown. During the same period patient was treated with VENTOLIN, SERETIDE, ELOXATIN. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported FLUOROURACIL problem on Mar 29, 2007. Female patient, 34 years of age, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, atrial fibrillation, chest pain, electrocardiogram st segment elevation, hypotension, ventricular hypokinesia. FLUOROURACIL dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 06, 2007. Female patient, weighting 125.4 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: diarrhoea. FLUOROURACIL dosage: 5334 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported FLUOROURACIL problem on Mar 30, 2007. Male patient, weighting 110.2 lb, was diagnosed with rectal cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. FLUOROURACIL dosage: 500 MG (340.1 MGM2) IV BOLUS FOLLOWED BY 2500 MG (1700.7 MG/M2) INFUSION ON D1+2. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM. Patient died on 12/29/2006.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Female patient, weighting 138.9 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, lung consolidation, lung infiltration, neutrophil count decreased, pharyngolaryngeal pain, platelet count decreased, white blood cell count decreased. FLUOROURACIL dosage: 6680 MG. During the same period patient was treated with MITOMYCIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUOROURACIL problem on Apr 09, 2007. Female patient, weighting 362.0 lb, was diagnosed with hypopharyngeal cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: catheter site erythema, catheter site pain, medical device pain. FLUOROURACIL dosage: 600MG/M2 IV QD X5D. During the same period patient was treated with HYDREA, CETUXIMAB. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Health Professional from UNITED STATES on Mar 29, 2007. Male patient, 71 years of age, was diagnosed with colorectal cancer metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, gastrointestinal erosion, hypertensive heart disease, intestinal ulcer perforation, pain, peritonitis. FLUOROURACIL dosage: 564 MILLIGRAM 1/2 WEEK, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with FOLINIC ACID, CETUXIMAB, BEVACIZUMAB, OLMESARTAN MEDOXOMIL, AMLODIPINE, VICODIN. Patient died on 02/18/2007.

Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Apr 10, 2007. Female patient, weighting 165.3 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, cardiomyopathy, myocardial infarction. FLUOROURACIL dosage: 29349 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2007. Male patient, weighting 245.2 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, chest pain, dysaesthesia pharynx, hypoaesthesia, malaise, muscle tightness, pain in extremity, paraesthesia, troponin. FLUOROURACIL dosage: 6468 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Apr 12, 2007. Female patient, weighting 117.9 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: dehydration, hypoxia, metabolic acidosis. FLUOROURACIL dosage: 4702 MG. During the same period patient was treated with CETUXIMAB, LEUCOVORIN CALCIUM, ELOXATIN, LEXAPRO, FENTANYL TRANSDERMAL SYSTEM, OXYCONTIN IR. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2007. Female patient, weighting 125.4 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: confusional state, diarrhoea, hypokalaemia, urinary tract infection. FLUOROURACIL dosage: 5334 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.

Health Professional from reported FLUOROURACIL problem on Apr 13, 2007. Female patient, weighting 105.8 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, pancytopenia. FLUOROURACIL dosage: 400 MG/M?, IV BOLUS D1+D2 FOLLOWED BY 5-FU 2400 MG/M? OVER 46-HOUR CONTINUOUS INFUSION.. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Pharmacist from UNITED STATES on Mar 30, 2007. Female patient, 65 years of age, was diagnosed with metastatic gastric cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: hypocalcaemia. FLUOROURACIL dosage: 1500 MG/M2, INTRAVENOUS. During the same period patient was treated with CETUXIMAB, CAMPTOSAR, FOLINIC ACID, ZOMETA. Patient was hospitalized. Patient recovered.

Health Professional from JAPAN reported FLUOROURACIL problem on Apr 09, 2007. Male patient was diagnosed with angina pectoris, convulsion, blood pressure management and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, metabolic acidosis. FLUOROURACIL dosage: 500 MG IV BOLUS (331.1MG/M2) FOLLOWED BY 3500 MG (2317.MG/M2) INFUSION ON D1+2. During the same period patient was treated with FRANDOL S, ALEVIATIN, PERDIPINE, DALACIN, UNASYN, OXYCONTIN, FLOMOX, NORVASC. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 19, 2007. Male patient, weighting 162.0 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, nausea, vomiting. FLUOROURACIL dosage: 5250 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Apr 19, 2007. Female patient, weighting 140.9 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bacterial infection, blood culture positive, cystitis escherichia, diarrhoea, gastrointestinal oedema, intussusception, nausea, neutropenia. FLUOROURACIL dosage: 6800 MG. During the same period patient was treated with MITOMYCIN, COMPAZINE, FLAGYL, NEXIUM, ZOSYN, SILVADENE, ZOFRAN, IMODIUM. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 19, 2007. Male patient, weighting 237.4 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: pneumonia. FLUOROURACIL dosage: 19460 MG. During the same period patient was treated with BEVACIZUMAB, CAMPTOSAR, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported FLUOROURACIL problem on Apr 11, 2007. Male patient, weighting 101.4 lb, was diagnosed with rectal cancer, sedation, prophylaxis against gastrointestinal ulcer, cardiac failure, catheter related infection, pyrexia and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: ileus, interstitial lung disease, respiratory failure. FLUOROURACIL dosage: 575 MG/BODY=399.3 MG/M2 BOLUS THEN 3575 MG/BODY=2482.6 MG/M2 INFUSION D1-2. During the same period patient was treated with OXALIPLATIN, FENTANYL, MIDAZOLAM, FAMOTIDINE, FUROSEMIDE, SULBACTAM CEFOPERAZONE, CEFAZOLIN, INDISETRON HYDROCHLORIDE. Patient was hospitalized. Patient died on 03/28/2007.

FLUOROURACIL problem was reported by a Health Professional from UNITED STATES on Apr 23, 2007. Female patient, weighting 90.00 lb, was diagnosed with colon cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: anorexia, dehydration, diarrhoea, nausea. FLUOROURACIL dosage: 730 MG D1, 8, 15, 22, 29, 36 IV. During the same period patient was treated with IMODIUM, NYSTATIN, LORCET, XANAX, PRILOSEC. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported FLUOROURACIL problem on Apr 20, 2007. Female patient, 56 years of age, weighting 112.0 lb, was diagnosed with colon cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: stomatitis. FLUOROURACIL dosage: 340MG QD IV. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2007. Female patient, 69 years of age, was diagnosed with gastric cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: dehydration, implant site cellulitis, nausea, renal failure, small intestinal obstruction, vomiting. FLUOROURACIL dosage: unknown. During the same period patient was treated with CISPLATIN, ARANESP, COUMADIN, DIOVAN, PRILOSEC, PROTONIX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Apr 24, 2007. Male patient, weighting 187.4 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: diarrhoea, mucosal inflammation. FLUOROURACIL dosage: 4525 MG. During the same period patient was treated with LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 24, 2007. Male patient, weighting 130.1 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, groin pain, neutropenia, renal failure. FLUOROURACIL dosage: 4450 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN, MEGACE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported FLUOROURACIL problem on Apr 04, 2007. Male patient, 64 years of age, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, electrocardiogram st segment elevation. FLUOROURACIL dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2007. Male patient, weighting 130.1 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: dyspnoea. FLUOROURACIL dosage: 4550 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUIM, ELOXATIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Apr 26, 2007. Male patient, weighting 130.1 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, groin pain, neutropenia, renal failure. FLUOROURACIL dosage: 4450 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Health Professional from UNITED STATES on Apr 12, 2007. Female patient, 76 years of age, was diagnosed with neoplasm malignant and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: colitis. FLUOROURACIL dosage: (225 MG/M2). Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUOROURACIL problem on Apr 17, 2007. Female patient, 53 years of age, was diagnosed with gastric cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, blood sodium decreased, carbon dioxide decreased, cheilitis, culture urine positive, dehydration, febrile neutropenia, haematocrit decreased. FLUOROURACIL dosage: unknown. During the same period patient was treated with CISPLATIN, HYZAAR, PROTONIX, FERROUS SULPHATE, DOCUSATE. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from FRANCE on Apr 16, 2007. Female patient, 41 years of age, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: bronchiolitis, cough, dyspnoea, dyspnoea at rest, hypoxia, lymphocyte percentage decreased, neutrophil percentage decreased, obliterative bronchiolitis, orthopnoea. FLUOROURACIL dosage: 950 MG INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CYCLOPHOSPHAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, EPIRUBICIN, ONDANSETRON, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Apr 27, 2007. Male patient, weighting 237.4 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: blood culture positive, escherichia infection. FLUOROURACIL dosage: 19460 MG. During the same period patient was treated with BEVACIZUMAB, CAMPTOSAR. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from GERMANY on Apr 13, 2007. Male patient, 74 years of age, was diagnosed with metastatic gastric cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: heart rate increased, pulmonary embolism, pyrexia. FLUOROURACIL dosage: 1500 MG/M2. During the same period patient was treated with FOLINIC ACID, CETUXIMAB, IRINOTECAN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUOROURACIL problem on Apr 20, 2007. Male patient, 62 years of age, was diagnosed with metastatic gastric cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: asthenia, hyperbilirubinaemia, hyperglycaemia, metabolic acidosis, renal failure. FLUOROURACIL dosage: CYCLE 1, DAY 1-5 EVERY 28 DAYS (1780 MG), INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CISPLATIN, APREPITANT, LORAZEPAM, ONDANSETRON, PROCHLORPERAZINE EDISYLATE, HYDROCODONE BITARTRATE. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2007. Female patient, weighting 135.0 lb, was diagnosed with neoplasm malignant and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: osteoporosis. FLUOROURACIL dosage: unknown. During the same period patient was treated with LEUCOVORIN NOT SURE. Patient recovered.

Physician from UNITED STATES reported FLUOROURACIL problem on Apr 20, 2007. Female patient, 76 years of age, was diagnosed with neoplasm malignant and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: colonic obstruction, ileus, peritonitis, proctitis, rectal cancer, sigmoiditis. FLUOROURACIL dosage: 225 MG/M2. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Physician from UNITED STATES on Apr 19, 2007. Male patient was diagnosed with neoplasm malignant and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: hepatic cirrhosis. FLUOROURACIL dosage: unknown. During the same period patient was treated with ELOXATIN, LEUCOVORIN CALCIUM. Patient died on 01/01/2007.

Physician from UNITED STATES reported FLUOROURACIL problem on Apr 27, 2007. Male patient, weighting 170.0 lb, was diagnosed with colorectal cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, pancytopenia. FLUOROURACIL dosage: unknown. During the same period patient was treated with ELOXATIN, LEUCOVORIN CALCIUM. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2007. Female patient, weighting 125.4 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: condition aggravated, confusional state, depression, diarrhoea, hypokalaemia, hypothyroidism, urinary tract infection. FLUOROURACIL dosage: 5334 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on May 04, 2007. Male patient, weighting 144.2 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, acute pulmonary oedema, dysphagia, ejection fraction decreased, heart rate increased, hypoxia, ill-defined disorder, loss of consciousness, lung infiltration. FLUOROURACIL dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOTERE. Patient was hospitalized. Patient died on 10/10/2004.

FLUOROURACIL problem was reported by a Health Professional from FRANCE on May 02, 2007. Male patient was diagnosed with pancreatic carcinoma metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: neutropenic sepsis. FLUOROURACIL dosage: 660 MG BOLUS FOLLOWED BY 2000 MG INFUSION. During the same period patient was treated with FOLINIC ACID, IRINOTECAN, OXALIPLATIN. Patient was hospitalized. Patient died on 08/29/2006.

Health Professional from FRANCE reported FLUOROURACIL problem on May 02, 2007. Male patient, weighting 138.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia. FLUOROURACIL dosage: 700 MG BOLUS FOLLOWED BY 2100 MG INFUSION. During the same period patient was treated with LEUCOVORIN CALCIUM, CPT, OXALIPLATIN. Patient died on 07/25/2006.

FLUOROURACIL problem was reported by a Pharmacist from UNITED STATES on May 04, 2007. Male patient, 52 years of age, was diagnosed with colon cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, hypotension, influenza. FLUOROURACIL dosage: 850MG IV DAILY. During the same period patient was treated with LEUCOVORIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on May 03, 2007. Male patient, weighting 149.9 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, nausea, vomiting. FLUOROURACIL dosage: 12460 MG. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Female patient, weighting 195.3 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, syncope. FLUOROURACIL dosage: 606 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN, DECADRON, ZOFRAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Apr 26, 2007. Female patient, 69 years of age, was diagnosed with gastric cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: catheter site cellulitis, dehydration, mucosal inflammation, nausea, neutropenia, pain, renal failure, small intestinal obstruction, vomiting. FLUOROURACIL dosage: unknown. During the same period patient was treated with CISPLATIN, ARANESP, COUMADIN, DIOVAN, PRILOSEC, PROTONIX. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Physician from JAPAN on May 02, 2007. Female patient, 68 years of age, was diagnosed with colon cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: infection, leukopenia, neutropenia. FLUOROURACIL dosage: 500 MG/BODY IN BOLUS THEN 600 MG/BODY AS INFUSION. During the same period patient was treated with LEUCOVORIN CALCIUM, OXALIPLATIN. Patient died on 04/26/2007.

Pharmacist from UNITED STATES reported FLUOROURACIL problem on May 09, 2007. Male patient, 52 years of age, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, hypotension, influenza serology positive. FLUOROURACIL dosage: unknown. During the same period patient was treated with LEUCOVORIN, KLONOPIN, DEXAMETHASONE, GUAIFENESIN DM, MAGIC MOUTHWASH, SIMVASTATIN, TRAZODONE. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2007. Male patient, weighting 145.3 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: chills, dizziness, febrile neutropenia, white blood cell count decreased. FLUOROURACIL dosage: 4788 MG. During the same period patient was treated with BEVACIZUMAB, CAMPTOSAR, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Apr 26, 2007. Female patient, 69 years of age, was diagnosed with gastric cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: dehydration, nausea, renal failure, small intestinal obstruction, vomiting. FLUOROURACIL dosage: CYCLE 2, DAYS 1-4 Q28 DAYS (1720 MG); INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Physician from UNITED KINGDOM on May 15, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: chest pain. FLUOROURACIL dosage: 975 MG, Q3W. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, EPIRUBICIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUOROURACIL problem on May 15, 2007. Male patient, weighting 159.0 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: axillary vein thrombosis, catheter related complication, deep vein thrombosis, subclavian vein thrombosis. FLUOROURACIL dosage: 600 MG/M2 IV QD. During the same period patient was treated with HYDREA, IRESSA. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on May 16, 2007. Male patient, weighting 140.0 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: diarrhoea, febrile neutropenia. FLUOROURACIL dosage: 3.9 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN, AVAPRO, HYTRIN, NEXIUM. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUOROURACIL problem on May 17, 2007. Male patient, weighting 120.8 lb, was diagnosed with laryngeal cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: blood culture positive, productive cough, pyrexia, sputum abnormal, staphylococcal bacteraemia. FLUOROURACIL dosage: 600 MG/M2 IV QD. During the same period patient was treated with HYDREA, CETUXIMAB. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Physician from UNITED KINGDOM on May 18, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: chest pain. FLUOROURACIL dosage: 975 MG, Q3W. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, EPIRUBICIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported FLUOROURACIL problem on May 11, 2007. Male patient, 65 years of age, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: liver abscess, vascular pseudoaneurysm. FLUOROURACIL dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from TURKEY on May 15, 2007. Male patient, 49 years of age, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: intracardiac thrombus. FLUOROURACIL dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Health Professional from JAPAN reported FLUOROURACIL problem on May 14, 2007. Female patient, weighting 108.0 lb, was diagnosed with colon cancer, disseminated intravascular coagulation, hypersensitivity and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. FLUOROURACIL dosage: 408MG/BODY=300MG/M2 IN BOLUS THEN 2720MG/BODY=2000MG/M2 AS CONTINUOUS INFUSION.. During the same period patient was treated with OXALIPLATIN, POLARAMINE, DECADRON, KYTRIL, ISOVORIN. Patient died on 04/10/2007.

FLUOROURACIL problem was reported by a Physician from UNITED STATES on May 07, 2007. Male patient, 79 years of age, was diagnosed with colorectal cancer metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood chloride increased, blood potassium decreased, dehydration, diarrhoea, haematocrit decreased, haemoglobin decreased, nausea, pyrexia. FLUOROURACIL dosage: 50. 2857 MG (704 MG, 1 IN 1 2 WK), INTRAVENOUS. During the same period patient was treated with CETUXIMAB, BEVACIZUMAB, LEUCOVORIN CALCIUM, SIMVASTATIN, CALTRATE, MAXIPIME, TOPROL, PROTONIX. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUOROURACIL problem on May 21, 2007. Male patient, weighting 227.1 lb, was diagnosed with malignant palate neoplasm and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: inadequate analgesia, mucosal inflammation, oral intake reduced, somnolence. FLUOROURACIL dosage: 600 MG/M2 IV QOW 5D. During the same period patient was treated with HYDREA, CETUXIMAB. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Physician from UNITED KINGDOM on May 22, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: chest pain. FLUOROURACIL dosage: 975 MG, Q3W. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, EPIRUBICIN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported FLUOROURACIL problem on May 07, 2007. Male patient, 79 years of age, was diagnosed with colorectal cancer metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood phosphorus decreased, blood potassium decreased, blood urea increased, decreased appetite, dehydration, diarrhoea, haematocrit decreased, haemoglobin decreased. FLUOROURACIL dosage: 50.2857 MG (704 MG, 1 IN 2 WK), INTRAVENOUS. During the same period patient was treated with CETUXIMAB, BEVACIZUMAB, LEUCOVORIN CALCIUM, SIMVASTATIN, CALTRATE, MAXIPIME, TOPROL, PROTONIX. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2007. Male patient, weighting 128.1 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: infection, neutrophil count abnormal, pain in extremity, proctalgia, rectal abscess. FLUOROURACIL dosage: unknown. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUOROURACIL problem on May 25, 2007. Male patient, weighting 156.3 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: cholangitis, febrile neutropenia. FLUOROURACIL dosage: 22000 MG. During the same period patient was treated with ELOXATIN. Patient was hospitalized. Patient recovered.

FLUOROURACIL problem was reported by a Physician from UNITED STATES on May 14, 2007. Female patient, 51 years of age, weighting 139.0 lb, was diagnosed with colorectal cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: acidosis, alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood glucose increased, brain natriuretic peptide increased. FLUOROURACIL dosage: 3024 MG, EVERY OTHER WEEK, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, BEVACIZUMAB, LISINOPRIL, METFORMIN, PANTOPRAZOLE, ACETYLSALICYLIC ACID SRT, AMLODIPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on May 18, 2007. Female patient, 69 years of age, was diagnosed with gastric cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: cellulitis, dehydration, mucosal inflammation, neutropenia, pain, renal failure, small intestinal obstruction. FLUOROURACIL dosage: unknown. During the same period patient was treated with CISPLATIN, ARANESP, COUMADIN, DIOVAN, PRILOSEC, PROTONIX. Patient was hospitalized. Patient recovered.

Showing 1-75 of 453 Next >